Search results
SHP report claims hospitals overcharging for oncology drugs
Winston-Salem Journal· 6 days agoThe program, known as 340B, was created by Congress in 1992 to financially assist hospitals serving...
Poll: 1 in 8 U.S. adults have tried weight-loss drugs like Wegovy, Ozempic - UPI.com
UPI· 4 days agoMost patients say they use the drugs (61%) to treat a chronic condition like diabetes or heart...
Tarsus Pharmaceuticals Inc (TARS) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth ...
GuruFocus.com via Yahoo Finance· 6 days agoExplore key financial outcomes and strategic insights from Tarsus Pharmaceuticals' first quarter of 2024, highlighting significant sales growth and market penetration efforts.
Cheaper medicines and a new approach for mental health care. Will the budget make us healthier?
The Conversation· 1 hour agoHealth was a centrepiece of last year’s budget, based on a new vision for Medicare. This year, there is less health reform, but the budget does set the foundation for a new ...
New KFF Poll Finds 1 in 8 Adults Say They’ve Taken a GLP-1 Drug (Ozempic, Trulicity, Wegovy),...
Sierra Sun Times· 2 days agoAbout one in eight adults (12%) say they have taken one of an increasingly popular class of prescription drugs known as GLP-1s that are used for weight loss and to treat diabetes ...
NC hospitals overcharge for drugs, treasurer says
The High Point Enterprise, N.C. via Yahoo Finance· 5 days agoMay 9—TRIAD — A number of hospitals across the state routinely charge patients drug prices that are many times what the hospital pays, and High Point's hospital has among ...
Some systems at Ascension St. Vincent interrupted after 'cybersecurity incident'
WTHR Indianapolis· 6 days agoAn Ascension St. Vincent spokesperson confirmed the company is still working to investigate a...
Karyopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
FOX 23 News Albany· 7 days ago– Announces Significant Refinancing Transactions and Amends Royalty Agreement with HealthCare Royalty Extending Vast Majority of Its Debt Maturities into 2028 and 2029, Well Beyond Expected ...